dc.contributor.author |
Taskesen, Fatih |
|
dc.contributor.author |
Cezairli, Burak |
|
dc.date.accessioned |
2024-03-15T08:35:44Z |
|
dc.date.available |
2024-03-15T08:35:44Z |
|
dc.date.issued |
2023 |
|
dc.identifier.citation |
Taskesen, F., Cezairli, B. (2023). Efficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobility. Cranio-J. Craniomandib. Sleep Pract., 41(5), 423-431. https://doi.org/10.1080/08869634.2020.1861887 |
en_US |
dc.identifier.issn |
0886-9634 |
|
dc.identifier.issn |
2151-0903 |
|
dc.identifier.uri |
http://dx.doi.org/10.1080/08869634.2020.1861887 |
|
dc.identifier.uri |
https://www.webofscience.com/wos/woscc/full-record/WOS:000599353400001 |
|
dc.identifier.uri |
http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4275 |
|
dc.description |
WoS Categories: Dentistry, Oral Surgery & Medicine |
en_US |
dc.description |
Web of Science Index: Science Citation Index Expanded (SCI-EXPANDED) |
en_US |
dc.description |
Research Areas: Dentistry, Oral Surgery & Medicine |
en_US |
dc.description.abstract |
Objective: The aim of this study was to compare the efficacy of dextrose prolotherapy in conjunction with arthrocentesis and dextrose prolotherapy alone in the management of symptomatic TMJ hypermobility. Methods: Twenty-four patients suffering from TMJ symptomatic hypermobility received 10% dextrose injections for three sessions at four-week intervals. Twelve patients (P group) received prolotherapy alone; the other 12 (PA group) also underwent a single arthrocentesis session. Patients were evaluated for maximal incisal opening, maximal incisal opening without pain, pain at rest, pain during chewing function, TMJ sound, and locking episode frequency. Results: Pain scores were significantly reduced in both groups, and the locking episode frequency was decreased to a greater extent in the PA than the P group, at both the short and long terms. Conclusion: Prolotherapy is effective in the management of TMJ hypermobility. However, prolotherapy with arthrocentesis may be superior to prolotherapy alone in the management of TMJ hypermobility. |
en_US |
dc.language.iso |
eng |
en_US |
dc.publisher |
TAYLOR & FRANCIS LTD-ABINGDON |
en_US |
dc.relation.isversionof |
10.1080/08869634.2020.1861887 |
en_US |
dc.rights |
info:eu-repo/semantics/openAccess |
en_US |
dc.subject |
Prolotherapy, arthrocentesis, temporomandibular joint |
en_US |
dc.subject |
DEXTROSE PROLOTHERAPY, AUTOLOGOUS BLOOD, DOUBLE-BLIND, INJECTION, EMINECTOMY, PLACEBO |
en_US |
dc.title |
Efficacy of prolotherapy and arthrocentesis in management of temporomandibular joint hypermobility |
en_US |
dc.type |
article |
en_US |
dc.relation.journal |
CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE |
en_US |
dc.contributor.department |
Ordu Üniversitesi |
en_US |
dc.contributor.authorID |
0000-0002-1196-9840 |
en_US |
dc.identifier.volume |
41 |
en_US |
dc.identifier.issue |
5 |
en_US |
dc.identifier.startpage |
423 |
en_US |
dc.identifier.endpage |
431 |
en_US |